Skip to main content

Table 2 Presenting Clinical Characteristics

From: Influence of Staphylococcus aureus on Outcomes after Valvular Surgery for Infective Endocarditis

  Overall (n = 323) SA IE (n = 85) NSA IE (n = 238) p - Value
NYHA Class     0.146
 Class 1 & 2 264 (81.7) 65 (76.5) 199 (83.6)
 Class 3 & 4 59 (18.3) 20 (23.5) 39 (16.4)
Fever, n (%) 194 (60.1) 60 (70.6) 134 (56.3) 0.021
Angina, n (%) 49 (15.2) 12 (14.1) 37 (15.6) 0.753
eGFR, (ml/min) 63.3 ± 33.6 58.9 ± 34.7 64.9 ± 33.2 0.161
  < 60 153 (47.4) 46 (54.1) 107 (45.0)
  ≥ 60 170 (52.6) 39 (45.9) 131 (55.0)
Vascular complications 143 (44.6) 50 (58.8) 93 (39.4) 0.002
Immunological phenomenon 65 (20.2) 19 (22.4) 46 (19.4) 0.562
New or worsening CHF 101 (31.3) 22 (25.9) 79 (33.2) 0.212
Persistent bacteremia 76 (23.6) 32 (37.7) 44 (18.6) 0.000
Leukocytosis 144 (44.6) 41 (48.2) 103 (43.3) 0.430
Pre-op septic shock, n (%) 53 (16.4) 20 (23.5) 33 (13.9) 0.039
Pre-op embolic event, n (%) 77 (24.0) 28 (33.3) 49 (20.7) 0.020
Pre-op stroke, n (%) 55 (17.0) 23 (27.1) 32 (13.5) 0.004
Pre-op MI, n (%) 29 (9.0) 8 (9.4) 21 (8.8) 0.871
Staph Aureus Species
 MRSA 21 (24.7)    
 MSSA 64 (75.3)    
Prosthetic Valve Endocarditis 109 (33.7) 29 (34.1) 80 (33.6)  
Affected Valves
 Aortic valve 206 (63.8) 42 (49.4) 164 (68.9) 0.001
 Mitral valve 192 (59.4) 56 (65.9) 136 (57.1) 0.159
 Tricuspid valve 27 (8.4) 10 (11.8) 17 (7.1) 0.186
  1. Values are means ± SD, or counts (%). NYHA New York Heart Association Class, GFR Glomerula Filtration Rate, CHF Congestive Heart Failure, MI Myocardial Infarction, MRSA Methicillin Resistant Staph Aureus, MSSA Methicillin Sensitive Staph Aureus